Oral complications of radiotherapy

Lancet Oncology

Volumn 7, Issue 2, 2006, Pages 175-183

  Sciubba, James J ^a   Goldenberg, David ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMIFOSTINE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; AZELASTINE; BENZYDAMINE; BETA CAROTENE; BIOLOGICAL RESPONSE MODIFIER; CHLORHEXIDINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYTOKINE; GLUTAMIC ACID; IMMUNOMODULATING AGENT; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 11; OPIATE; OXYGEN; PALIFERMIN; PENTOXIFYLLINE; PILOCARPINE; PROSTAGLANDIN DERIVATIVE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SUCRALFATE; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG;

BLADDER DYSFUNCTION; BONE DISEASE; BONE NECROSIS; CANCER PATIENT; CELL PROTECTION; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE CLASSIFICATION; DISEASE EXACERBATION; ENTEROPATHY; FLUSHING; HEAD AND NECK CANCER; HUMAN; HYPERBARIC OXYGEN; IONIZING RADIATION; MASTICATORY MUSCLE; MOUTH HYGIENE; MOUTH PAIN; MUCOSA INFLAMMATION; MUSCLE DISEASE; ORAL MUCOSAL DISEASE; PATHOGENESIS; PHYSIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SALIVARY GLAND DISEASE; SIDE EFFECT; SWEATING; SYMPTOMATOLOGY; TOOTH DISEASE; TRISMUS; XEROSTOMIA;

HUMANS; JAW DISEASES; OSTEORADIONECROSIS; RADIATION INJURIES; STOMATITIS; STOMATOGNATHIC DISEASES; TRISMUS; XEROSTOMIA;

EID: 31544436908     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(06)70580-0     Document Type: Review

References (82)

1. Herrstedt J Prevention and management of mucositis in patients with cancer Int J Antimicrob Agents 16 2000 161-163
2. JD Cox J Stetz TF Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341-1346
3. J Bourhis A Etessami A Lusinchi New trends in radiotherapy for head and neck cancer Ann Oncol 16 suppl 2 2005 ii255-ii257
4. D Archibald PB Lockhart ST Sonis et al. Oral complications of multimodality therapy for advanced squamous cell carcinoma of head and neck Oral Surg Oral Med Oral Pathol 61 1986 139-141
5. ST Sonis AL Sonis A Lieberman Oral complications in patients receiving treatment for malignancies other than of the head and neck J Am Dent Assoc 97 1978 468-472
6. RL Engelmeier GE King Complications of head and neck radiation therapy and their management J Prosthet Dent 49 1983 514-522
7. JT Parsons WM Mendenhall NJ Cassisi et al. Hyperfractionation for head and neck cancer Int J Radiat Oncol Biol Phys 14 1988 649-658
8. JT Parsons NJ Cassisi RR Million Results of twice-a-day irradiation of squamous cell carcinomas of the head and neck Int J Radiat Oncol Biol Phys 10 1984 2041-2051
9. KK Fu TF Pajak VA Marcial et al. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: Long-term follow-up results of RTOG 83-13 Int J Radiat Oncol Biol Phys 32 1995 577-588
10. ST Sonis Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity Oral Oncol 34 1998 39-43
11. U Al-Tikriti MV Martin PA Bramley A pilot study of the clinical effects of irradiation on the oral tissues Br J Oral Maxillofac Surg 22 1984 77-86
12. C Scully J Epstein S Sonis Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: Part 1, pathogenesis and prophylaxis of mucositis Head Neck 25 2003 1057-1070
13. JH Meurman P Laine C Lindqvist et al. Five-year follow-up study of saliva, mutans streptococci, lactobacilli and yeast counts in lymphoma patients Oral Oncol 1997 33 439-443
14. C Scully J Epstein S Sonis Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: Diagnosis and management of mucositis Head Neck 26 2004 77-84
15. A Trotti LA Bellm JB Epstein et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review Radiother Oncol 66 2003 253-262
16. National Cancer Institute National Cancer Institute common toxicity criteria, version 3.0 2003 National Cancer Institute Bethesda, MA
17. National Institutes of Health Consensus Development Conference on Oral Complications of Cancer Therapies: Diagnosis, prevention, and treatment. Bethesda, Maryland, April, 17-19, 1989 NCI Monographs 9 1990 1-184
18. HV Worthington JE Clarkson OB Eden Interventions for treating oral mucositis for patients with cancer receiving treatment Cochrane Database Syst Rev 2 2004 CD001973
19. JB Epstein Silverman S Jr DA et al. Paggiarino Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: Results from a multicenter, randomized, double-blind, placebo-controlled clinical trial Cancer 92 2001 875-885
20. JH Kim FC Chu V Lakshmi R Houde Benzydamine HCl, a new agent for the treatment of radiation mucositis of the oropharynx Am J Clin Oncol 9 1986 132-134
21. CE Saadeh Chemotherapy- and radiotherapy-induced oral mucositis: Review of preventive strategies and treatment Pharmacotherapy 25 2005 540-554
22. DT Brown CH Miller DE Maupin The effect of sucralfate on the growth of cariogenic streptococci J Prosthet Dent 66 1991 256-260
23. SJ Konturek T Brozozowski W Bielanski et al. Epidermal growth factor in the gastroprotective and ulcer-healing actions of sucralfate in rats Am J Med 86 1989 32-37
24. P Pfeiffer O Hansen EL Madsen O May A prospective pilot study on the effect of sucralfate mouth-swishing in reducing stomatitis during radiotherapy of the oral cavity Acta Oncol 29 1990 471-473
25. G Barker L Loftus P Cuddy B Barker The effects of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis Oral Surg Oral Med Oral Pathol 71 1991 288-293
26. JB Epstein FL Wong The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy Int J Radiat Oncol Biol Phys 28 1994 693-698
27. V Kannan PP Bapsy N Anantha et al. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma Int J Radiat Oncol Biol Phys 37 1997 1005-1010
28. J Buntzel M Glatzel K Kuttner et al. Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer Semin Radiat Oncol 12 suppl 1 2002 4-13
29. P Lissoni S Barni M Mandala et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status Eur J Cancer 35 1999 1688-1692
30. R Spielberger P Stiff W Bensinger et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers N Engl J Med 351 2004 2590-2598
31. JS Cooper K Fu J Marks S Silverman Late effects of radiation therapy in the head and neck region Int J Radiat Oncol Biol Phys 31 1995 1141-1164
32. PJ Hughes PM Scott J Kew et al. Dysphagia in treated nasopharyngeal cancer Head Neck 22 2000 393-397
33. V Ramirez-Amador Silverman S Jr et al. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84 1997 149-153
34. MS Kies DJ Haraf F Rosen et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer J Clin Oncol 19 2001 1961-1969
35. KS Chao N Majhail CJ Huang et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: A comparison with conventional techniques Radiother Oncol 61 2001 275-280
36. SR Porter C Scully AM Hegarty An update of the etiology and management of xerostomia Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 2004 28-46
37. G Jenkins The physiology of the mouth Jenkins G The physiology of the mouth 3rd edn. 1966 Blackwell Scientific Publications Oxford 328
38. S Rauch Die speicheldrusen des menschen Rauch S Anatomie, physiologie, und klinische pathologie 1959 Thieme Stuttgart
39. LC Stephens TE Schultheiss SM Small et al. Response of parotid gland organ culture to radiation Radiat Res 120 1989 140-153
40. LC Stephens TE Schultheiss RE et al. Price Radiation apoptosis of serous acinar cells of salivary and lacrimal glands Cancer 67 1991 1539-1543
41. GM Paardekooper S Cammelli LJ Zeilstra et al. Radiation-induced apoptosis in relation to acute impairment of rat salivary gland function Int J Radiat Biol 73 1998 641-648
42. AW Konings RP Coppes A Vissink On the mechanism of salivary gland radiosensitivity Int J Radiat Oncol Biol Phys 62 2005 1187-1194
43. SP Reddy CR Leman JE Marks B Emami Parotid-sparing irradiation for cancer of the oral cavity: Maintenance of oral nutrition and body weight by preserving parotid function Am J Clin Oncol 24 2001 341-346
44. MS Chambers Garden MS Kies JW Martin Radiation-induced xerostomia in patients with head and neck cancer: Pathogenesis, impact on quality of life, and management Head Neck 26 2004 796-807
45. A Eisbruch HM Kim JE Terrell et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer Int J Radiat Oncol Biol Phys 50 2001 695-704
46. JM Roesink AW Konings CH Terhaard et al. Preservation of the rat parotid gland function after radiation by prophylactic pilocarpine treatment: radiation dose dependency and compensatory mechanisms Int J Radiat Oncol Biol Phys 45 1999 483-489
47. C Scully JB Epstein Oral health care for the cancer patient Eur J Cancer B Oral Oncol 32B 1996 281-292
48. HM Patt SH Mayer RL Straube EM Jackson Radiation dose reduction by cysteine J Cell Physiol 42 1953 327-341
49. PM Calabro-Jones RC Fahey GD Smoluk JF Ward Alkaline phosphatase promotes radioprotection and accumulation of WR-1065 in V79-171 cells incubated in medium containing WR-2721 Int J Radiat Biol Relat Stud Phys Chem Med 47 1985 23-27
50. S McDonald C Meyerowitz T Smudzin P Rubin Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction Int J Radiat Oncol Biol Phys 29 1994 747-754
51. DM Brizel TH Wasserman M Henke et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer J Clin Oncol 18 2000 3339-3345
52. TH Wasserman DM Brizel M Henke et al. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and-neck cancer: 2-year follow-up of a prospective, randomized, phase III trial Int J Radiat Oncol Biol Phys 63 2005 985-990
53. D Rades F Fehlauer A Bajrovic et al. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients Radiother Oncol 70 2004 261-264
54. PR Anne Phase ll trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer Semin Oncol 29 suppl 19 2002 80-83
55. A Lin HM Kim JE Terrell et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study Int J Radiat Oncol Biol Phys 57 2003 61-70
56. BS Henson MR Inglehart A Eisbruch JA Ship Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy Oral Oncol 37 2001 84-93
57. JG Malouf C Aragon BS Henson et al. Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients Cancer Detect Prev 27 2003 305-310
58. S Bourdin P Desson G Leroy et al. Prevention of post-irradiation xerostomia by submaxillary gland transposition Ann Otolaryngol Chir Cervicofac 99 1982 265-268
59. H Seikaly N Jha T McGaw et al. Submandibular gland transfer: A new method of preventing radiation-induced xerostomia Laryngoscope 111 2001 47-352
60. H Seikaly N Jha JR Harris et al. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia Arch Otolaryngol Head Neck Surg 130 2004 956-961
61. A Vissink FR Burlage FK Spijkervet et al. Prevention and treatment of the consequences of head and neck radiotherapy Crit Rev Oral Biol Med 14 2003 213-225
62. A Vissink E Johannes's-Gravenmade AK Panders A Vermey Treatment of hyposalivation Ear Nose Throat J 67 1988 179-185
63. JT Johnson GA Ferretti WJ Nethery et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer N Engl J Med 329 1993 390-395
64. P Warde B O'Sullivan J Aslanidis et al. A phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer Int J Radiat Oncol Biol Phys 54 2002 9-13
65. JA Ship K Hu Radiotherapy-induced salivary dysfunction Semin Oncol 31 suppl 18 2004 29-36
66. W Niedermeier C Matthaeus C Meyer et al. Radiation-induced hyposalivation and its treatment with oral pilocarpine Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86 1998 541-549
67. RP Zimmerman RJ Mark LM Tran GF Juillard Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia Int J Radiat Oncol Biol Phys 37 1997 571-575
68. FB Vivino Al-Hashimi Z Khan et al. for the P92-01 Study Group Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: A randomized, placebo-controlled, fixed-dose, multicenter trial Arch Intern Med 159 1999 174-181
69. F Thomas F Ozanne G Mamelle et al. Radiotherapy alone for oropharyngeal carcinomas: The role of fraction size (2 Gy vs 2·5 Gy) on local control and early and late complications Int J Radiat Oncol Biol Phys 15 1988 1097-1102
70. R Steelman J Sokol Quantification of trismus following irradiation of the temporomandibular joint Mo Dent J 66 1986 21-23
71. A Vissink J Jansma FK Spijkervet et al. Oral sequelae of head and neck radiotherapy Crit Rev Oral Biol Med 14 2003 199-212
72. CJ Wang EY Huang HC Hsu et al. The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer Laryngoscope 115 2005 1458-1460
73. DT Chua C Lo J Yuen YC Foo A pilot study of pentoxifylline in the treatment of radiation-induced trismus Am J Clin Oncol 24 2001 366-369
74. T Reuther T Schuster U Mende A Kubler Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients - a report of a thirty year retrospective review Int J Oral Maxillofac Surg 32 2003 289-295
75. G Studer KW Gratz C Glanzmann Osteoradionecrosis of the mandibula in patients treated with different fractionations Strahlenther Onkol 180 2004 233-240
76. JK Wong RE Wood M McLean Conservative management of osteoradionecrosis Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84 1997 16-21
77. Annane D Depondt J Aubert P et al. Hyperbaric oxygen therapy for radionecrosis of the jaw: A randomized, placebo-controlled, double-blind trial from the ORN96 study group J Clin Oncol 22 2004 4893-4900
78. D Pasquier T Hoelscher J Schmutz et al. Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissues: A literature review Radiother Oncol 72 2004 1-13
79. BA Jereczek-Fossa R Orecchia Radiotherapy-induced mandibular bone complications Cancer Treat Rev 28 2002 65-74
80. S Delanian JL Lefaix The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway Radiother Oncol 73 2004 119-131
81. RA Myers RE Marx Use of hyperbaric oxygen in postradiation head and neck surgery NCI Monogr 9 1990 151-157
82. F Sulaiman JM Huryn IM Zlotolow Dental extractions in the irradiated head and neck patient: A retrospective analysis of Memorial Sloan-Kettering Cancer Center protocols, criteria, and end results J Oral Maxillofac Surg 61 2003 1123-1131